Michael P Heffernan Selected Research

Michael P Heffernan Research Topics

6	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2015 - 01/2007
3	Rheumatoid Arthritis 02/2016 - 07/2007
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2010 - 07/2007
2	Bullous Pemphigoid (Pemphigoid) 11/2006 - 10/2006
2	Sarcoidosis (Schaumann Disease) 01/2006 - 07/2005
1	Inflammation (Inflammations) 12/2014
1	Primitive Neuroectodermal Tumors (PNET) 08/2011
1	Psoriatic Arthritis 03/2010
1	Atopic Dermatitis (Atopic Eczema) 01/2010
1	Eczema 01/2010
1	Malaria 12/2009
1	Hyperpigmentation 12/2009
1	Vitiligo 02/2008
1	Pyoderma Gangrenosum 03/2007
1	Lichen Planus (Lichen Ruber Planus) 03/2007
1	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 11/2006
1	Blindness (Hysterical Blindness) 11/2006
1	Cicatrix (Scar) 11/2006
1	Paronychia 08/2006
1	Acneiform Eruptions 08/2006
1	Alopecia (Baldness) 08/2006
1	Seborrheic Dermatitis 08/2006
1	Cutaneous Lupus Erythematosus 05/2006
1	Osteoporosis 03/2006
1	Alopecia Areata 12/2005
1	Discoid Lupus Erythematosus 09/2005
1	Acne Vulgaris 03/2004
1	Connective Tissue Diseases (Connective Tissue Disease) 06/2002

4	Etanercept (Enbrel)FDA Link 08/2015 - 11/2006
3	Interleukin-17 (Interleukin 17)IBA 02/2016 - 12/2014
3	ixekizumabIBA 02/2016 - 12/2014
3	Infliximab (Remicade)FDA Link 10/2012 - 07/2005
3	Adalimumab (Humira)FDA Link 02/2008 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016 - 10/2012
2	Rituximab (Mabthera)FDA Link 07/2010 - 07/2007
2	Alefacept (Amevive)FDA Link 03/2010 - 12/2005
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2010 - 09/2005
2	Ointments (Pastes)IBA 01/2010 - 09/2005
2	efalizumab (Raptiva)FDA Link 03/2007 - 05/2006
1	Monoclonal AntibodiesIBA 02/2016
1	Prostaglandins AIBA 10/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010
1	SteroidsIBA 01/2010
1	pimecrolimus (Elidel)FDA Link 01/2010
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2009
1	Immunologic Factors (Immunomodulators)IBA 01/2007
1	Matrix Metalloproteinases (MMPs)IBA 11/2006
1	Gefitinib (Iressa)FDA Link 08/2006
1	ErbB Receptors (EGF Receptor)IBA 08/2006
1	GlucocorticoidsIBA 03/2006
1	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)IBA 03/2004
1	5-alpha Reductase InhibitorsIBA 03/2004
1	Minocycline (Cyclops)FDA LinkGeneric 03/2004
1	Antinuclear AntibodiesIBA 06/2002